BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36778374)

  • 1. SATB2 loss in inflammatory bowel disease-associated small intestinal metaplasia of the distal colon.
    Zeineldin M; Larman TC
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children.
    Simmonds N; Furman M; Karanika E; Phillips A; Bates AW
    BMC Gastroenterol; 2014 May; 14():93. PubMed ID: 24885054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease.
    Tanaka M; Saito H; Kusumi T; Fukuda S; Shimoyama T; Sasaki Y; Suto K; Munakata A; Kudo H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1353-9. PubMed ID: 11851832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis.
    Ayata G; Ithamukkala S; Sapp H; Shaz BH; Brien TP; Wang HH; Antonioli DA; Farraye FA; Odze RD
    Am J Surg Pathol; 2002 Nov; 26(11):1414-23. PubMed ID: 12409717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SATB2 Expression Is a Biomarker of Inflammatory Bowel Disease-associated Colorectal Dysplasia and Adenocarcinoma.
    Ma C; Henn P; Miller C; Herbst C; Hartman DJ; Pai RK
    Am J Surg Pathol; 2019 Oct; 43(10):1314-1322. PubMed ID: 31318711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Loss of SATB2 Expression in Inflammatory Bowel Disease Indefinite for Dysplasia and a Diagnosis of Definitive Dysplasia on Follow-up.
    Cretara A; Knee A; Mueller J; Jawale R
    Am J Surg Pathol; 2022 Aug; 46(8):1137-1141. PubMed ID: 35405720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease.
    Musulen E; Gené M; Cuatrecasas M; Amat I; Veiga JA; Fernández-Aceñero MJ; Chimisana VF; Tarragona J; Jurado I; Fernández-Victoria R; Martínez-Ciarpaglini C; Alenda González C; Zac C; Fernández-Figueras MT; Esteller M
    Hum Pathol; 2024 Jan; 143():50-61. PubMed ID: 38000679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression.
    Iwaya M; Ota H; Tateishi Y; Nakajima T; Riddell R; Conner JR
    Mod Pathol; 2019 Jun; 32(6):884-892. PubMed ID: 30710095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.
    Gu W; Wang H; Huang X; Kraiczy J; Singh PNP; Ng C; Dagdeviren S; Houghton S; Pellon-Cardenas O; Lan Y; Nie Y; Zhang J; Banerjee KK; Onufer EJ; Warner BW; Spence J; Scherl E; Rafii S; Lee RT; Verzi MP; Redmond D; Longman R; Helin K; Shivdasani RA; Zhou Q
    Cell Stem Cell; 2022 Jan; 29(1):101-115.e10. PubMed ID: 34582804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB2 Defect Promotes Colitis and Colitis-associated Colorectal Cancer by Impairing Cl-/HCO3- Exchange and Homeostasis of Gut Microbiota.
    Ni H; Chen Y; Xia W; Wang C; Hu C; Sun L; Tang W; Cui H; Shen T; Liu Y; Li J
    J Crohns Colitis; 2021 Dec; 15(12):2088-2102. PubMed ID: 34019628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
    Gui X; Iacucci M; Ghosh S
    Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.
    Iwaya M; Ota H; Nakajima T; Uehara T; Riddell R; Conner J
    BMC Cancer; 2021 Feb; 21(1):119. PubMed ID: 33541282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
    Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
    Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.